Boryung Pharmaceutical Co. made $200 million contract including licensing-out contract of 'Kanarb'
On Jan 9, Boryung Pharmaceutical Co. made a licensing-out contract about new hypertension drug 'Kanarb' with Gloria in China, followed by 13 countries in Latin America including Mexico, Brazil, Russia.
Boryung Pharmaceutical Co. provides licence of new hypertension drug 'K...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
